Daniel McFadden, PhD

213-821-7955
email

Daniel McFadden is the Presidential Professor of Health Economics at the University of Southern California and conducts research at the USC Schaeffer Center. He has joint appointments at the USC Price School of Public Policy and the Department of Economics at the USC Dornsife College of Letters, Arts and Sciences.

He was awarded the Nobel Prize in Economic Sciences in 2000, along with James Heckman, for the development of theories and methods for analyzing discrete choice. His research focuses on the fields of econometrics, economic theory and mathematical economics, health economics and environmental economics.

McFadden's extraordinary body of work includes more than 100 scholarly articles published in numerous journals, including the Journal of the American Statistical Association, Journal of Public Economics, Journal of Econometrics, Econometrica, American Economic Review, Journal of Economic Theory, Journal of Political Economy, Journal of Mathematical Economics, Advances in Applied Micro-Economics, and the Review of Economics and Statistics, among many others.

He was elected to the American Academy of Arts and Sciences in 1977 and to the National Academy of Sciences in 1981. He is also the recipient of the Frisch Medal from the Econometric Society and the Nemmers Prize in Economics from Northwestern University.

Before joining USC, he directed the Econometrics Laboratory at the University of California, Berkeley.

Recent Work

Medicare Part D Beneficiaries’ Self-reported Barriers to Switching Plans and Making Plan Comparisons at All

Over half of Medicare beneficiaries in stand-alone Part D plans kept their coverage without comparing plans during the last enrollment period, and many reported not knowing how to switch plans.
Categorized in
- Research
- Journal Articles
Disparate Aging: The Role of Education and Socioeconomic Gradients in Future Health and Disability in an International Context

If on one side ageing is driven by biological changes, on the other side the ageing itself reflects the accumulated effects of one’s exposure to a history of external risks, and can further be influenced by social changes, such as isolation and loss of loved ones.
Categorized in
Improved Survival for Individuals with Common Chronic Conditions in the Medicare Population

It is well established that the United States lags behind peer nations in life expectancy, but it is less established that there is heterogeneity in life expectancy trends. We compared mortality trends from 2004 to 2014 for the United States with 17 high-income countries for persons under and over 65. The United States ranked last […]
Categorized in
- Research
- Journal Articles
COVID-19 – How Bad Can It Get?

McFadden offers a short analysis of a worst-case scenario for the COVID-19 epidemic. Under a worst-case scenario, he says to expect 4.4 million deaths in the U.S. age 60+ population this year, and a peak demand for more than 1.8 million hospital beds.

By Daniel McFadden, PhD
Categorized in
- Evidence Base
Switch and Save on Medicare Part D

Simply switching prescription drug plans could save seniors and the government billions.

By Daniel McFadden, PhD and Joachim Winter
Categorized in
- Articles
- Perspective

Daniel McFadden, PhD's contact information

Daniel McFadden, PhD's Bio

Recent Work

Medicare Part D Beneficiaries’ Self-reported Barriers to Switching Plans and Making Plan Comparisons at All

Disparate Aging: The Role of Education and Socioeconomic Gradients in Future Health and Disability in an International Context

Improved Survival for Individuals with Common Chronic Conditions in the Medicare Population

COVID-19 – How Bad Can It Get?

Switch and Save on Medicare Part D